An Open-Label Study to Assess the Effect of AZD5672 at Steady State on the Pharmacokinetics of Digoxin Following Single Dose Administration in Healthy Volunteers.
Phase of Trial: Phase I
Latest Information Update: 18 May 2017
At a glance
- Drugs AZD 5672; Digoxin
- Indications Heart failure; Rheumatoid arthritis
- Focus Pharmacokinetics
- Sponsors AstraZeneca
- 09 Jan 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 18 Aug 2008 New trial record.